Order your free hard copy by adding to cart or you can download an electronic copy for free using the link below
Order your free hard copy by adding to cart or you can download an electronic copy for free using the link below
The final clinical considerations that emerged from the report include:
• Some patients with high opioid tolerance may require buprenorphine doses >24 mg per day during the stabilization phase of treatment.
• Physiological changes during pregnancy alter buprenorphine metabolism, necessitating an adjusted buprenorphine dose and increased dosing frequency.
• Dose and frequency adjustments, psychosocial supports, and a higher level of care should be considered if individuals are unable to stabilize on < 24 mg/day buprenorphine.
• Reassessment of higher (>24 mg/day) doses should be considered once patients enter long-term treatment without ongoing use of opioids.
This project is funded under a grant contract with the State of Tennessee,
Department of Mental Health and Substance Abuse Services.


Address
1321 Murfreesboro Pike #155
Nashville, TN 37217
United States
615-780-5901